TORBICA, ALEKSANDRA
 Distribuzione geografica
Continente #
EU - Europa 8.712
NA - Nord America 4.400
AS - Asia 1.403
AF - Africa 50
SA - Sud America 27
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 6
Totale 14.617
Nazione #
IT - Italia 5.286
US - Stati Uniti d'America 4.174
IE - Irlanda 963
GB - Regno Unito 710
CN - Cina 530
UA - Ucraina 400
DE - Germania 339
SG - Singapore 259
SE - Svezia 245
CA - Canada 211
TR - Turchia 185
FI - Finlandia 149
FR - Francia 143
VN - Vietnam 118
NL - Olanda 84
BG - Bulgaria 64
KR - Corea 63
HK - Hong Kong 56
IN - India 50
DK - Danimarca 48
ID - Indonesia 48
BE - Belgio 46
ES - Italia 33
RU - Federazione Russa 29
CZ - Repubblica Ceca 27
AL - Albania 22
CH - Svizzera 22
RO - Romania 22
EU - Europa 18
IR - Iran 18
TN - Tunisia 18
GR - Grecia 17
TH - Thailandia 16
AT - Austria 14
BR - Brasile 14
PL - Polonia 10
EG - Egitto 9
PT - Portogallo 9
JP - Giappone 8
MA - Marocco 8
PH - Filippine 7
AE - Emirati Arabi Uniti 6
LV - Lettonia 6
ZA - Sudafrica 6
AZ - Azerbaigian 5
NI - Nicaragua 5
AU - Australia 4
IL - Israele 4
MX - Messico 4
MY - Malesia 4
NO - Norvegia 4
BY - Bielorussia 3
EC - Ecuador 3
GE - Georgia 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MW - Malawi 3
PA - Panama 3
PE - Perù 3
SM - San Marino 3
AR - Argentina 2
BO - Bolivia 2
DZ - Algeria 2
EE - Estonia 2
HU - Ungheria 2
IQ - Iraq 2
KE - Kenya 2
KH - Cambogia 2
LT - Lituania 2
LY - Libia 2
MC - Monaco 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AD - Andorra 1
BD - Bangladesh 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
MD - Moldavia 1
MK - Macedonia 1
PY - Paraguay 1
RS - Serbia 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 14.617
Città #
Dublin 957
Milan 852
Chandler 573
Rome 503
Ann Arbor 474
Houston 473
Southend 446
Jacksonville 330
Singapore 194
New York 193
Toronto 182
Ashburn 149
Dearborn 142
Beijing 120
Dong Ket 111
Wilmington 102
Turin 101
Frankfurt am Main 90
Lawrence 89
Helsinki 86
Naples 85
Boardman 82
Izmir 79
Boston 76
Modena 72
Bologna 67
Woodbridge 66
Mountain View 65
Seoul 63
Florence 55
Redwood City 55
Hong Kong 52
Redmond 51
Los Angeles 46
Seattle 45
Jakarta 44
Fairfield 40
Brussels 38
Genoa 38
Padova 36
Bari 31
Washington 29
Hefei 28
Palermo 28
Palombara Sabina 28
Munich 27
Brescia 24
Catania 24
Duncan 24
Nanjing 24
Cambridge 21
Falls Church 21
Dallas 18
Fremont 18
Nardò 18
Reggio Emilia 18
Taranto 18
Trieste 17
Latina 15
Pescara 15
London 14
Ottawa 14
Jinan 13
Kunming 13
Monza 13
Napoli 13
Perugia 13
Treviso 13
Verona 13
Vicenza 13
Bergamo 12
Guangzhou 12
Norwalk 12
Paris 12
Pisa 12
Trento 12
Athens 11
Bucharest 11
Foggia 11
Lappeenranta 11
Livorno 11
Nanchang 11
Robbiate 11
Torino 11
Auburn Hills 10
Campobasso 10
Dalmine 10
Parma 10
Pavia 10
Rimini 10
San Mateo 10
Shanghai 10
Tirana 10
Amsterdam 9
Brno 9
Cagliari 9
Trapani 9
Arezzo 8
Catanzaro 8
Cinisello Balsamo 8
Totale 8.210
Nome #
Analisi dei costi della procedura angioplastica coronarica per via transradiale in regime ambulatoriale in Italia 4.178
La funzione di HTA nelle aziende sanitarie italiane: un potenziale ancora inutilizzato? 323
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci 302
European Society of Cardiology: cardiovascular disease statistics 2019 241
Basic principles of health technology assessment, economic evaluation, and costing of healthcare programs 237
Dinamiche economiche e performance del settore dei dispositivi medici in Italia 235
Programma nazionale HTA per dispositivi medici: quali sfide per l’implementazione? 207
Impatto del sistema di finanziamento a DRG sull’innovazione tecnologica in sanità. Il caso italiano 190
Financing medical devices in Italy and Spain 189
Programma Nazionale di HTA per dispositivi medici: prove tecniche di implementazione 178
Economic evaluation of medical devices 175
Systematic literature review on the spread of health-related misinformation on social media 173
The economic crisis and acute myocardial infarction: new evidence using hospital-level data 169
What factors drive heterogeneity of preferences for micro-health insurance in rural Malawi? 165
Understanding the impact of economic evidence on clinical decision making: a discrete choice experiment in cardiology 165
The role of hospital payments in the adoption of new medical technologies: an international survey of current practice 150
Myth #5: health care is rightly left to the private sector, for the sake of efficiency 148
Diffusion without evidence: a study on high-risk medical devices 140
Learning effect and diffusion of innovative medical devices: the case of transcatheter aortic valve implantation in Italy 134
Do social values and institutional context shape the use of economic evaluation in reimbursement decisions? An empirical analysis 134
Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data 132
Challenges in the assessment of medical devices: the MedtecHTA Project 132
Cost utility analysis of microprocessor controlled knee prosthesis in Italy 130
Sustainability of Universal Health Coverage: Five Continents, Four Perspectives 129
Key reccomendations from the MedtecHTA project 128
Comparing the efficiency of hospitals in Italy and Germany: nonparametric conditional approach based on partial frontier 126
Does the approach to economic evaluation in health care depend on culture, values, and institutional context? 124
HTA around the world: broadening our understanding of cross-country differences 124
Direct costs of intracranial aneurysm treatment in the Italian hospitals 123
Epidemiology of cardiovascular disease in Europe 122
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies 121
Funding and Regulating Health Technologies in Decentralized Systems: A Comparison between Italy and Spain 120
Il governo regionale dell'assistenza farmaceutica: un quadro delle iniziative adottate nel 2003 119
Does informal care impact utilization of healthcare services? Evidence from a longitudinal study of stroke patients 119
Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project 119
Health care multidisciplinary teams: the sociotechnical approach for an integrated system-wide perspective 118
Adoption decisions for medical devices in the field of cardiology: results from a European survey 117
Inpatient reimbursement system in Italy: how do tariffs relate to costs? 115
I processi di valutazione dei dispositivi medici e delle tecnologie sanitarie 114
Core outcome set in surgical oncology: why, what and how to measure 114
Analisi dei costi di quattro strategie terapeutiche nella gestione di pazienti con broncopneumopatia (BPCO) moderata o severa: un'applicazione del modello bootstrap 112
Financing medical devices: The case of implantable cardioverter defibrillators and coronary stents in Italy 112
Tariffe e finanziamento dell'innovazione tecnologica: analisi generale e focus su due casi regionali 111
Five year trends (2008-2012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases 110
Should health technology assessment be more patient centric? If so, how? 108
Cost and reimbursement of cataract surgery in Europe: a cross country comparison 105
Investigating regional variation of cardiac implantable electrical device implant rates in European healthcare systems: what drives differences? 105
Costing and performance in healthcare management 105
Diffusion and use of Health Technology Assessment in policy making: what lessons for decentralised healthcare systems? 103
Economic evaluation of user-fee exemption policies for maternal healthcare in Burkina Faso: evidence from a cost-effectiveness analysis 101
Assessing the added value of health technologies: reconciling different perspectives 100
At what cost is performance-based financing implemented? Novel evidence from Malawi 100
Investigating the geographic disparity in quality of care: the case of hospital readmission after acute myocardial infarction in Italy 99
Cost-effectiveness of a programme of screening and brief interventions for alchool in primary care in Italy 97
Impatto economico nella prospettiva del paziente: spese out-of-pocket, perdite di produttività e costi dell’assistenza informale 95
Generating appropriate clinical data for value assessment of medical devices: what role does regulation play? 94
Traveling for care: Inter-regional mobility for aortic valve substitution in Italy 93
Expanding the role of early health economic modelling in evaluation of health technologies. Comment on "Problems and promises of health technologies: the role of early health economic modeling" 93
Alcune riflessioni prima di tirare le somme 93
Incentivizing research into the effectiveness of medical devices 92
What criteria guide national entrepreneurs' policy decisions on user fee removal for maternal health care services? Use of a best-worst scaling choice experiment in West Africa. 91
Uptake and diffusion of medical technology innovation in Europe: what role for funding and procurement policies? 90
Explaining the health costs associated with managing intracranial aneurysms in Italy 89
Implant rates of cardiac implantable electrical devices in Europe: a systematic literature review 88
Coverage with evidence development for medical devices in Europe: can practice meet theory? 88
Facts. Figures! Fiction? 86
The "Essential Levels of Care" in Italy: when being explicit serves the devolution of powers 85
The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study 85
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal 84
Equità territoriale: definizioni, evidenze empiriche e politiche appropriate 81
A new strategy for health and sustainable development in the light of the COVID-19 pandemic 81
Patient, hospital and country-level risk factors of all-cause mortality among patients with chronic heart failure: prospective international cohort study 76
Transformation of cancer care during and after the COVID pandemic, a point of no return : the experience of Italy 76
Hospital cost of central line-associated bloodstream infections and cost-effectiveness of closed vs. open infusion containers. The case of Intensive Care Units in Italy 75
Economic Evaluation in Health Care: the Point of View of Informed Physicians 74
Evaluating complex health financing interventions: using mixed methods to inform further implementation of a novel PBI intervention in rural Malawi 71
European Union regulation of health technology assessment: what is required for it to succeed? 71
Eliciting preferences to inform patient-centered policies: the case of psoriasis 67
Eliciting community preferences for complementary micro health insurance: A discrete choice experiment in rural Malawi. 60
Blood donation in times of crisis: early insight into the impact of COVID‐19 on blood donors and their motivation to donate across European countries 59
Inequalities in avoidable hospitalisation in large urban areas: retrospective observational study in the metropolitan area of Milan 58
Lifecycle evidence requirements for high-risk implantable medical devices: a European perspective 55
Healthcare services for undocumented migrants : organisation and costs from the Italian NHS perspective 54
Risk communication during COVID-19: a descriptive study on familiarity with, adherence to and trust in the WHO preventive measures 53
A cohort study on diabetic undocumented migrants in Italy: can charitable organizations contribute to higher adherence? 52
Investigating patients’ preferences to inform drug development decisions: novel Insights from a discrete choice experiment in migraine 51
Quo vadis HTA for medical devices in Central and Eastern Europe? Recommendations to address methodological challenges 48
Collecting physicians' preferences on medical devices: are we doing it right? Evidence from Italian orthopedists using 2 different stated preference methods 45
Psychometric evaluation of the Mental Health Quality of Life (MHQoL) instrument in seven European countries 44
How real can we get in generating real world evidence? Exploring the opportunities of routinely collected administrative data for evaluation of medical devices 42
The role of technology and social media use in sleep-onset difficulties among Italian adolescents: cross-sectional study 41
Real-world evidence in health technology assessment of high-risk medical devices: fit for purpose? 40
Economic burden of cardiovascular diseases in the European Union: a population-based cost study 37
Longitudinal associations between different measures of socioeconomic status and health behavior among adolescents. Data from a wealthy Italian region 36
Spillover effects and other determinants of medical device uptake in the presence of a medical guideline: an analysis of drug-eluting stents in Germany and Italy 36
A repeated cross-sectional analysis on the economic impact of SARS-CoV-2 pandemic at the hospital level in Italy 35
Challenges of health technology assessment in pluralistic healthcare systems: an ISPOR council report 34
Depression and anxiety in later COVID-19 waves across Europe: new evidence from the European COvid Survey (ECOS) 31
Prioritizing COVID-19 vaccine allocation in resource poor settings: towards an Artificial Intelligence-enabled and geospatial-assisted decision support framework 30
How much does it cost to combine supply-side and demand-side RBF approaches in a single intervention? Full cost analysis of the Results Based Financing for Maternal and Newborn Health Initiative in Malawi 29
Totale 14.735
Categoria #
all - tutte 53.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.180 0 0 0 0 0 0 313 233 169 199 115 151
2020/20211.720 121 140 89 175 198 153 160 64 158 126 134 202
2021/20221.635 79 209 54 59 119 63 100 197 150 188 205 212
2022/20233.744 234 222 103 300 242 274 180 264 1.341 167 248 169
2023/20243.050 175 139 188 150 239 382 317 327 158 241 362 372
2024/20251.553 247 131 305 273 302 290 5 0 0 0 0 0
Totale 14.899